Reader TTS

Access through your institution Buy or subscribe Honig, H. _ et al_. Intrajejunal levodopa infusino in Parkinsons disease: a pilot multicenter study of effects on nonmotor symptoms and

quality of life. _Mov. Disord._ doi:10.1002/mds.22596 Previous studies have shown that, compared with oral levodopa medication, continuous infusion of levodopa–carbidopa (duodopa) gel

reduces motor complications in advanced Parkinson disease (PD). A study by Honig and colleagues has, for the first time, explored the effects of infusion of intrajejunal duodopa on nonmotor

symptoms in advanced PD cases. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12

print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be

subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors *

Lisa Richards View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE

Richards, L. Intrajejunal duodopa improves nonmotor symptoms. _Nat Rev Neurol_ 5, 354 (2009). https://doi.org/10.1038/nrneurol.2009.84 Download citation * Issue Date: July 2009 * DOI:

https://doi.org/10.1038/nrneurol.2009.84 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative